Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 12(8): e0182480, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28796788

RESUMO

The protozoan Entamoeba histolytica is the etiological agent of amoebiasis, which can spread to the liver and form amoebic liver abscesses. Histological studies conducted with resistant and susceptible models of amoebic liver abscesses (ALAs) have established that neutrophils are the first cells to contact invasive amoebae at the lesion site. Myeloperoxidase is the most abundant enzyme secreted by neutrophils. It uses hydrogen peroxide secreted by the same cells to oxidize chloride ions and produce hypochlorous acid, which is the most efficient microbicidal system of neutrophils. In a previous report, our group demonstrated that myeloperoxidase presents amoebicidal activity in vitro. The aim of the current contribution was to analyze in vivo the role of myeloperoxidase in a susceptible (hamsters) and resistant (Balb/c mice) animal models of ALAs. In liver samples of hamsters and mice inoculated intraportally with Entamoeba histolytica trophozoites, the number of neutrophils in ALAs was determined by enzymatic activity. The presence of myeloperoxidase was observed by staining, and its expression and activity were quantified in situ. A significant difference existed between the two animal models in the number of neutrophils and the expression and activity of myeloperoxidase, which may explain the distinct evolution of amoebic liver abscesses. Hamsters and mice were treated with an MPO inhibitor (4-aminobenzoic acid hydrazide). Hamsters treated with ABAH showed no significant differences in the percentage of lesions or in the percentage of amoebae damaged compared with the untreated hamsters. ABAH treated mice versus untreated mice showed larger abscesses and a decreased percentage of damaged amoebae in these lesion at all stages of evolution. Further studies are needed to elucidate the host and amoebic mechanisms involved in the adequate or inadequate activation and modulation of myeloperoxidase.


Assuntos
Entamoeba histolytica/fisiologia , Abscesso Hepático Amebiano/enzimologia , Peroxidase/metabolismo , Animais , Cricetinae , Modelos Animais de Doenças , Resistência à Doença , Interações Hospedeiro-Patógeno , Elastase de Leucócito/metabolismo , Fígado/enzimologia , Fígado/imunologia , Fígado/parasitologia , Masculino , Camundongos Endogâmicos BALB C , Neutrófilos/enzimologia
2.
Parasite ; 23: 6, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26880421

RESUMO

Host invasion by Entamoeba histolytica, the pathogenic agent of amebiasis, can lead to the development of amebic liver abscess (ALA). Due to the difficulty of exploring host and amebic factors involved in the pathogenesis of ALA in humans, most studies have been conducted with animal models (e.g., mice, gerbils, and hamsters). Histopathological findings reveal that the chronic phase of ALA in humans corresponds to lytic or liquefactive necrosis, whereas in rodent models there is granulomatous inflammation. However, the use of animal models has provided important information on molecules and mechanisms of the host/parasite interaction. Hence, the present review discusses the possible role of neutrophils in the effector immune response in ALA in rodents. Properly activated neutrophils are probably successful in eliminating amebas through oxidative and non-oxidative mechanisms, including neutrophil degranulation, the generation of free radicals (O2(-), H2O2, HOCl) and peroxynitrite, the activation of NADPH-oxidase and myeloperoxidase (MPO) enzymes, and the formation of neutrophil extracellular traps (NETs). On the other hand, if amebas are not eliminated in the early stages of infection, they trigger a prolonged and exaggerated inflammatory response that apparently causes ALAs. Genetic differences in animals and humans are likely to be key to a successful host immune response.


Assuntos
Abscesso Hepático Amebiano/imunologia , Neutrófilos/imunologia , Animais , Apoptose , Degranulação Celular , Hipóxia Celular , Cricetinae , Suscetibilidade a Doenças , Entamoeba histolytica/genética , Entamoeba histolytica/fisiologia , Armadilhas Extracelulares , Feminino , Gerbillinae , Inflamação , Abscesso Hepático Amebiano/patologia , Masculino , Camundongos , Camundongos SCID , Modelos Animais , NADPH Oxidases/fisiologia , Peroxidase/fisiologia , Ratos , Explosão Respiratória , Especificidade da Espécie
3.
Biomed Res Int ; 2014: 324230, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24822193

RESUMO

The molecular mechanisms by which Entamoeba histolytica causes amebic liver abscess (ALA) are still not fully understood. Amebic mechanisms of adherence and cytotoxic activity are pivotal for amebic survival but apparently do not directly cause liver abscess. Abundant evidence indicates that chronic inflammation (resulting from an inadequate immune response) is probably the main cause of ALA. Reports referring to inflammatory mechanisms of liver damage mention a repertoire of toxic molecules by the immune response (especially nitric oxide and reactive oxygen intermediates) and cytotoxic substances released by neutrophils and macrophages after being lysed by amoebas (e.g., defensins, complement, and proteases). Nevertheless, recent evidence downplays these mechanisms in abscess formation and emphasizes the importance of peroxynitrite (ONOO(-)). It seems that the defense mechanism of amoebas against ONOO(-), namely, the amebic thioredoxin system (including peroxiredoxin), is superior to that of mammals. The aim of the present text is to define the importance of ONOO(-) as the main agent of liver abscess formation during amebic invasion, and to explain the superior capacity of amoebas to defend themselves against this toxic agent through the peroxiredoxin and thioredoxin system.


Assuntos
Interações Hospedeiro-Parasita , Abscesso Hepático Amebiano , Modelos Biológicos , Peroxirredoxinas , Ácido Peroxinitroso , Animais , Linhagem Celular , Cricetinae , Humanos , Inflamação , Camundongos , Ratos
4.
Can J Microbiol ; 56(12): 987-95, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21164568

RESUMO

Trophozoites of Entamoeba histolytica HM-1:IMSS become less virulent after long-term maintenance in axenic cultures. The factors responsible for the loss of virulence during in vitro cultivation remain unclear. However, it is known that in vitro cultivation of amoeba in culture medium supplemented with cholesterol restores their virulence. In this study, we analyzed the effect of adding phosphatidylcholine-cholesterol (PC-Chol) liposomes to the culture medium and evaluated the effect of this lipid on various biochemical and biological functions of E. histolytica HM-1:IMSS in terms of its virulence. The addition of PC-Chol liposomes to the culture medium maintained the virulence of these parasites against hamster liver at the same level as the original virulent E. histolytica strain, even though these amoebae were maintained without passage through hamster liver for 18 months. The trophozoites also showed increased endocytosis, erythrophagocytosis, and carbohydrate residue expression on the amoebic surface. Protease activities were also modified by the presence of cholesterol in the culture medium. These findings indicate the capacity of cholesterol to preserve amoeba virulence and provide an alternative method for the maintenance of virulent E. histolytica trophozoites without the need for in vivo procedures.


Assuntos
Colesterol/farmacologia , Entamoeba histolytica/efeitos dos fármacos , Entamoeba histolytica/patogenicidade , Abscesso Hepático Amebiano/parasitologia , Fosfatidilcolinas/farmacologia , Animais , Colesterol/análise , Concanavalina A/análise , Cricetinae , Meios de Cultura/química , Endocitose/efeitos dos fármacos , Entamoeba histolytica/enzimologia , Entamoeba histolytica/crescimento & desenvolvimento , Eritrócitos/efeitos dos fármacos , Lipossomos/farmacologia , Masculino , Peptídeo Hidrolases/metabolismo , Fagocitose/efeitos dos fármacos , Trofozoítos/efeitos dos fármacos , Trofozoítos/enzimologia , Trofozoítos/crescimento & desenvolvimento , Virulência/efeitos dos fármacos , Fatores de Virulência/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA